SCIEX QTRAP® 6500 LC-MS/MS System Demonstrates Exceptional Sensitivity and Selectivity in Method Development

Addressing the need for fast, reliable and accurate mass spectrometry-based assays in the field of clinical research

LC-MS/MS based methods are highly sensitive and achieve extremely low limits of detection, thus overcoming the performance of some immunoassays limited by interference issue. "The advantages of using the QTRAP 6500 for our research are that it has the best available selectivity and sensitivity; it produces exceptionally reliable results as well as providing the highest uptime," said Dr. Carsten Schriver Højskov, Aarhus University Hospital. The laboratory also owns two SCIEX 5500 systems, four SCIEX QTRAP 6500 systems, and a TripleTOF^® 5600 instrument.

"We have always had a good experience with SCIEX instruments and we have received excellent service from the company through collaboration with their application specialists," added Dr. Carsten Schriver Højskov.

"The research excellence achieved by our customers is a true indicator of the quality of our instruments and the strength of our application specialists and global support teams," said Chris Radloff, Global Vice President & General Manager of the LC-MS Business at SCIEX. "We listen carefully to what our customers need to support their applications, and SCIEX innovates to exceed those needs."

Learn more about the SCIEX QTRAP 6500 System.